http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021014103-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_859a1c14b9c49d1234e9fa4deba9681e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2020-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7eed7718af393990561eb5bcf9aca6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c3bd58583122f938c1d4e89b1e1dca7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ee231ce703c3f631c3ba02e50019195
publicationDate 2021-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021014103-A1
titleOfInvention Particulate structures made from gold nanoparticles, methods for preparing same and uses thereof for treating solid tumours
abstract The present invention concerns a particulate structure characterised in that it comprises: a/ a biodegradable polymer particle, b/ gold nanoparticles covered on their surface with macrocyclic chelators complexing at least one ion of interest and/or a radionucleide for medical imaging, c/ a polycation having a positive charge over a pH range from 5 to 11, the gold nanoparticles b/ being encapsulated in the polymer particle a/ and/or adsorbed at the surface of the polymer particle a/. The invention also relates to a method for preparing the particulate structures. The invention further concerns the use of the particulate structures for radiotherapy or chemotherapy in the context of cancer treatment.
priorityDate 2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012007567-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012124502-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006222595-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9974870-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID311028037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453277883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6911919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452606145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411168116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434370

Total number of triples: 84.